Skip to main content

  • Health Care Professionals

  • Patients

  • EnglishEnglish
    • CanadaCanada > English
    • CanadaCanada > French

  • Sunovion Pharmaceuticals Inc. logo.

  • Product Innovation

    • Product Innovation

    • Pipeline

    • Psychiatry

    • Neurology

    • Additional Therapies

    • Scientific Publications

  • Careers

    • Careers

    • Job Search

    • Benefits

    • Career Growth

  • Partnerships

    • Partnerships

    • Submission Process

  • Responsibility

    • Responsibility

    • Building Communities

    • Advocating for Patients

  • About Us

    • About Us

    • Mission, Vision & Values

    • People & Culture

    • Executive Leadership

    • Diversity & Inclusion

    • Contact Us

  • News & Media

    • News & Media

    • Media Kit

  • Health Care Professionals

  • Patients

Press Releases

ENGLISH
US
ENGLISH
EUROPE
ENGLISH
CANADA
ENGLISH FRENCH
GLOBAL
ENGLISH
  • Home
  • Who We Are
    • Who We are overview
    • Our Mission, Vision & Values
    • Executive Leadership
      • Nobuhiko Tamura
      • Greg Bokar
      • Matthew D'Ambrosio
      • David Frawley
      • Stephen Freeman
      • Robert Gregorio
      • Antony Loebel
    • Our History
    • Our People
      • Jeffrey Akin
      • Robin Cruz
      • John Gallo
      • Katrina Iserman
      • Henry McMillan
      • Daniel Yi
  • Join Us
    • Join us overview
    • Benefits
    • Job Search
    • Special Programs
    • General Warning to Job Seekers
  • Responsibility
    • Responsibility overview
    • Patient Support & Advocacy
    • Community Building
  • Our Therapies
    • Oor Therapies Overview
    • Aptiom® (eslicarbazepine acetate) tablets
    • Brovana® (aformoterol tartrate) Inhalation Solution
    • Latuda® (lurasidone HCi) tablets
    • Lonhala® Magnair® (glycopyrrolate) Inhalation Solution
    • Lunesta® (eszopiclone) tablets
    • Xopenex® HFA (levalbuterol tartrate) Inhalation Aerosol
  • Research & Development
    • Research & Development overview
    • Our Pipeline
    • Psychiatric Disorders Overview
    • Neurological Disorders Overview
    • Respiratory Disorders Overview
    • Research Grants
    • Disclosure of Clinical Study Data
  • Explore Partnerships
    • Explore Partnerships Overview
    • Our Partners
    • Partnering Contact Form
  • Featured News
  • Health Care Professionals
  • Our Patients
  • Media
  • Contact Us

Follow us on:

  • Featured News Overview
    • Press Releases

Press Releases

Sunovion Logo
    • Product Innovation
    • Careers
    • Partnerships
    • Responsibility
    • About Us
    • News & Media
    • Patient Support
    • SunovionSupport.com
    • HCP Support
    • SunovionProFile.com
    • SunovionMedical.com
    • Resources
    • Procurement
    • SunovionIISGrants.com
    • SunovionIMEGrants.com
    • Sumitomo Dainippon Pharma

    • Contact Us

  • Terms of Use
  • Privacy Policy & Cookie Notice
  • Medical Disclaimer
  • Social Media Community Guidelines
  • Sources
  • Sitemap
  • Corporate Transparency Documents

SUNOVION, Sunovion logo, and LATUDA are registered trademarks of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Dainippon Pharma Co., Ltd.

APTIOM is a registered trademark of Bial logo , used under license.

LONHALA and Lonhala Magnair logo are registered trademarks of Sunovion Pharmaceuticals Inc. MAGNAIR is a registered trademark of PARI Pharma GmbH, used under license.

eFlow and eLete are registered trademarks of PARI Pharma GmbH.

KYNMOBI and Kynmobi logo are registered trademarks of Sunovion Pharmaceuticals Inc.

© 2023 Sunovion Pharmaceuticals Inc. All rights reserved.

Powered By Q4 Inc. 5.103.0.4 (opens in new window)